Xynomic Pharma Doses First Chinese Patient in Pivotal Phase 3 Kidney Cancer Trial and Hires Medical Monitor

September 13, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search